コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 esuscitation results in smaller increases in plasma sodium.
2 and their severity, as well as the level of plasma sodium.
4 [HR], 1.73 per 1 mmol/L per hour decrease in plasma sodium; 95% confidence interval [95% CI], 1.23 to
6 tic patients, cachectic patients had reduced plasma sodium and increased norepinephrine, epinephrine
8 nel (ENaC) participates in the regulation of plasma sodium and volume, and gain of function mutations
10 fidence interval, 0.72 to 0.88) mmol/L lower plasma sodium, but we observed no gene-environment inter
11 primary end point was the absolute change in plasma sodium concentration after 4 days of treatment.
12 of isosal on hemodynamics, brain edema, and plasma sodium concentration after head injury associated
13 the role of genetic variation in regulating plasma sodium concentration and highlight the importance
14 the effects on the cerebellum of the rise of plasma sodium concentration and the emergence of thirst
15 tion between a polygenic score developed for plasma sodium concentration and thiazide exposure on sod
17 1, we identified eight loci associated with plasma sodium concentration at P<5.0 x 10(-6) Of these,
18 ad a significantly higher increase of median plasma sodium concentration compared with those receivin
19 nome-wide association study meta-analysis on plasma sodium concentration in 45,889 individuals of Eur
25 ed genome-wide association study analyses of plasma sodium concentration, thiazide-induced decrease i
27 igate the relationship between dialysate and plasma sodium concentrations and mortality among mainten
28 idence interval, 1.25 to 1.98), adjusted for plasma sodium concentrations and other confounding varia
29 level as in the rats on solid chow; however, plasma sodium concentrations and plasma osmolality remai
31 tic study identified 31 loci associated with plasma sodium concentrations in individuals of European
33 show any evidence of effect modification by plasma sodium concentrations or other patient-specific v
40 ney transplant recipients failed to maintain plasma sodium during water loading (plasma sodium slope
41 sociation between time-varying dialysate and plasma sodium exposure and all-cause mortality, adjusted
42 (2.02 +/- 0.96 L) was FW loss, and increased plasma sodium from 139 (range: 135-143 mmol/L) to 143 (r
43 HS challenge, healthy volunteers displayed a plasma sodium increase of [Formula: see text] and [Formu
44 had decreased from 79.7 to 78.8 kg, and mean plasma sodium increased from 140.4 to 142.6 mmol/L (both
45 es did not correlate with either the initial plasma sodium level (r=0.05, P>.12) or the rate of corre
46 n of plasma oxytocin or copeptin levels with plasma sodium level at 180 minutes (peak concentration o
51 eived empagliflozin had a larger increase in plasma sodium levels compared with those who received pl
52 ean decrease (+/- one half of the 95% CI) in plasma sodium levels of 0.9 +/- 0.9 mmol/L from a mean o
53 restriction cycle, significant decreases in plasma sodium levels of 1.23 +/- 0.5 mmol/L (from values
54 m chloride before respiratory insufficiency, plasma sodium levels were increased by 22 (10) mmol/L in
55 ong patients who had fluid restriction only, plasma sodium levels were increased by 3 (2) mmol/L in 4
56 um chloride after respiratory insufficiency, plasma sodium levels were increased by 30 (6) mmol/L in
62 dialysate sodium (<=138 or >138 mmol/L) and plasma sodium (<135, 135-142, >142 mmol/L) concentration
64 ng time-updated Glasgow Coma Scale (GCS) and plasma sodium measurements, together with patient baseli
65 in 30 (37%) (P = .002) with a difference in plasma sodium of 4 (95% CI, 2-5) mEq/L (P < .001) betwee
67 al positive psychotic symptoms (P < .09) and plasma sodium (P < .18) were even marginally associated
68 fidence interval, 0.39 to 0.46) mmol/L lower plasma sodium per SD decrease, and thiazide use was asso
71 maintain plasma sodium during water loading (plasma sodium slope of -0.6+/-0.4 mmol/L per hour in tra
72 ases the strong ion difference by increasing plasma sodium, tris-hydroxymethyl aminomethane acts by i
74 ed from body composition (WD(4)), the actual plasma sodium (WD(5)), the substitution of plasma osmola